The Technical Analyst
PowerShares Dynamic [PBE]
Exchange: NYSE
PowerShares Dynamic Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.63% $63.75
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 290.06 mill |
| EPS: | 3.77 |
| P/E: | 16.90 |
| Earnings Date: | N/A |
| SharesOutstanding: | 4.55 mill |
| Avg Daily Volume: | 0.0156 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.71x |
| Company: PE 16.90 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.25x |
| Company: PE 16.90 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 62.93 - 64.57 ( +/- 1.29%) |
| ATR Model: 14 days |
Forecast:
16:00 - $63.75
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $63.75
Forecast 2: 16:00 - $63.75
Forecast 3: 16:00 - $63.75
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $63.75 (-0.63% ) |
| Volume | 0.0061 mill |
| Avg. Vol. | 0.0156 mill |
| % of Avg. Vol | 39.45 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PBE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PBE
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Latest News
2024-04-01 10:30:00 - Seeking Alpha
PBE: Biotech Could Be Next Big Winner
Biotechnology and genomics sector has not performed well in recent years, making it an attractive investment opportunity. The Invesco Biotechnology & Genome ETF offers comprehensive exposure to the biotech sector with a diversified portfolio. PBE has performed better than some similar ETFs but worse than others, highlighting the importance of stock selection in this sector.
2024-03-13 07:21:13 - Zacks Investment Research
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
2024-03-05 07:21:11 - Zacks Investment Research
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
2024-02-19 16:08:49 - InvestorPlace
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
Biotech stocks, namely those involved with gene editing, have been explosive. Just look at CRISPR Therapeutics (NASADQ: CRSP ), for example.
2024-02-14 17:51:14 - Zacks Investment Research
Where Are Biotech ETFs Headed After Q4 Earnings?
2024-02-12 17:21:06 - InvestorPlace
The Best Time to Invest
2024-01-16 11:28:14 - ETF Trends
An ETF Nerd's Exchange Conference Preview
The long-awaited spot bitcoin ETFs are trading after a decade of waiting. So now the ETF and advisor community has some available brain capacity to look forward.
2024-01-09 18:03:00 - Zacks Investment Research
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.
2024-01-03 07:31:13 - Zacks Investment Research
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
2023-11-08 07:31:22 - Zacks Investment Research
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.